A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

Credit: Getty Images. Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for ...

The FDA has approved mirabegron for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. The drug, marketed by Astellas Pharma Inc.

Groundbreaking research reveals that long-term use of common drugs for depression, bladder control, and Parkinson’s could be ...

NEW YORK, June 6 (Reuters) - One of the most common problems in the United States -- an overactive bladder -- is so poorly treated by the current crop of drugs that new medicines have big sales ...

(Reuters) - Watson Pharmaceuticals Inc said it signed a deal to market Antares Pharma Inc's experimental treatment for overactive bladder in the United States and Canada. According to the terms of the ...

It can be annoying if your bladder seems to work overtime and you're headed to the bathroom more often than you'd like, but that doesn't necessarily mean you need medication or that you even have a ...

Bladder leaks can be disruptive—and they’re very common. Up to 30 percent of older adults experience incontinence. The problem is more prevalent in women, but the percentage of men with an overactive ...

You’re driving somewhere, eyes on the road, when you start to feel a tingling sensation in your lower abdomen. That extra-large Coke you drank an hour ago has made its way through your kidneys into ...

Active ingredient: Fesoterodine fumarate 4 mg, 8 mg; extended-release tablets. Indication: Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency. Pharmacology: Fesoterodine ...